Suven Life Sciences Gains Over 4% On Bagging Product Patents

By Religare
Subscribe to GoodReturns
For Quick Alerts
For Daily Alerts

    Shares of Suven Life Sciences rose over 4 per cent on Bombay Stock Exchange (BSE) after the company announced it secures three product patents two from Canada and one from China for a drug used in the treatment of neuro-degenerative diseases.

    Check the share price details

    Suven Life Sciences Gains Over 4% On Bagging Product Patents
    Suven Life Sciences: Quotes, News
    BSE 247.45BSE Quote7.2 (-2.91%)
    NSE 247.80NSE Quote8.45 (-3.41%)

    The patents are valid until 2029 and 2030, respectively, Suven Life Sciences said in a filing to the BSE.

    "The company grant of two product patents from Canada and one product patent from China corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases," Suven Life Sciences said in a press release.

    Reacting to the news, shares of the company gained 4.44 per cent to Rs 242.20 a piece on BSE.

    In a similar trend, shares of the company surged 3.93 per cent to Rs 241.95 a piece on National Stock Exchange.

    Meanwhile, the broader benchmark BSE Sensex was trading at 25,848.45, up 142.52 points, or 0.55 per cent at 11.00 hours.

    Read more about: suven life sciences
    Company Search
    Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

    Find IFSC

    Get Latest News alerts from Goodreturns

    We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more